Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Phenotype C0011847|diabetes
Sentences 65
PubMedID- 24260287 Obesity and diabetes are associated with increased breast cancer risk and worse disease progression once cancer is diagnosed; however, the exact etiology behind these observations remains to be fully elucidated.
PubMedID- 20077000 In conclusion, type 2 diabetes is associated with poor breast cancer prognosis.
PubMedID- 23401790 The combined evidence overall supported a modest association between type 2 diabetes and the risk of breast cancer, which was found to be more prevalent among postmenopausal women.
PubMedID- 26185535 Most studies for the identification of risk factors for breast cancer among women with diabetes have concentrated on type 2 dm and have failed to discriminate between types 1 and 2. therefore, any correlations to type 1 dm remain dubious 15. we conducted a general female population-based cohort study to assess the implications of type1/2 diabetes mellitus in breast cancer development.
PubMedID- 25866823 In the taiwan study, breast cancer patients with diabetes had a significantly increased mortality with a hazard ratio (hr) of 1.57 (95% ci: 1.15–2.15) [118].
PubMedID- 23244125 Objective: the aim was to investigate indicators related to dna damage and cancer pathogenesis in type ii diabetes cases with breast cancer.
PubMedID- 26171401 Studies also suggested a higher risk of breast cancer in women with prediabetes [23] and type 2 diabetes [24], both are characterized by endogenous hyperinsulinemia resulting from insulin resistance.
PubMedID- 22996614 The potential of an increased risk of breast cancer in women with diabetes has been the subject of a great deal of recent research.
PubMedID- 21972408 Previous epidemiologic research suggests a modestly elevated risk of breast cancer in women with type 2 diabetes (t2d), particularly after menopause (1).
PubMedID- 22296353 Methods: 105 breast cancer patients with type-2 diabetes mellitus (dm) presenting from january 2005 to december 2010 were enrolled in this study.
PubMedID- 23138438 Recent findings: in the past year, studies have shifted focus from effects on cardiovascular disease and diabetes to effects of mets on breast cancer as well as menopausal symptoms.
PubMedID- 25679392 Whether the increased mortality risk among breast cancer survivors with diabetes is driven by an increase in cancer recurrence or a result of competing diabetes-related comorbidities such as cardiovascular disease remains unclear.
PubMedID- 24281091 Currently, the comorbidity and interaction of diabetes with breast cancer is arousing great research interest.
PubMedID- 25866793 A study by currie and colleagues showed that mortality increased in elderly breast cancer patients with diabetes, and metformin treatment improved survival rates in comparison with other diabetic treatments (sulfonylureas and insulin) and compared to a nondiabetic patient cohort [29].
PubMedID- 26537234 Mammalian target of rapamycin (mtor) is activated by insulin and insulin-mediated breast cancer progression in patients with type 2 diabetes mellitus may be abrogated by inhibition of mtor [5].
PubMedID- 22261802 This will largely draw the attention of hdl-based treatments in the diabetes patients with breast cancer.
PubMedID- 24349656 Pre-existing diabetes increased the risk of breast cancer significantly only in the post-menopause group (or, 1.44; 95% ci, 1.03 to 2.01), whereas it showed no significant association in the pre-menopause group.
PubMedID- 21632448 diabetes is associated with postmenopausal breast cancer, too, with summary rrs from meta-analyses of 1.15-1.20, but not with premenopausal breast cancer (rr, 0.9).
PubMedID- 25723884 Dexrazoxane protects breast cancer patients with diabetes from chemotherapy-induced cardiotoxicity.
PubMedID- 25779100 diabetes was associated with more advanced-stage breast cancer, even after accounting for differences in screening mammogram use and other factors.
PubMedID- 23292119 In total, the study included 1,013 breast cancer patients with diabetes and 4,621 breast cancer patients without diabetes.
PubMedID- 23259613 Our objectives were to identify factors associated with previously undiagnosed diabetes in breast cancer, and to examine associations between previously undiagnosed diabetes and cancer stage, treatment patterns, and mortality.
PubMedID- 23826297 However, the increased risk of breast cancer associated with diabetes (i.e., 42%) noted in our study was comparable with those of previous studies [1]–[3], [8].
PubMedID- 23949559 Conclusions this international study found no difference in the risk of developing breast cancer in patients with diabetes among the different types of insulin with short- to mid-term duration of use.
PubMedID- 22848683 Increased risk of breast cancer has been associated with diabetes in numerous epidemiological studies [27], therefore we also studied the effect of insulin analogues on the production of pip3 in breast cancer derived cell lines using a new, highly sensitive bret-based assay.
PubMedID- 23829168 Both cohort and case–control epidemiological observations have demonstrated the association of metabolic syndrome, obesity and diabetes with increased breast cancer risk [5,6].
PubMedID- 23882052 (30) have recently published a detailed meta-analysis of breast cancer in diabetes, concluding that there may be a 27% increase in type 2 diabetes but not in type 1 diabetes or gestational diabetes mellitus where insulin use is universal or more common.
PubMedID- 21115861 Purpose: self-reported diabetes has been associated with poor breast cancer outcomes.
PubMedID- 25107658 Studies have shown an increased risk of breast cancer associated with diabetes which may be due to differences in mammography use among women who have diabetes compared with women who do not have diabetes.
PubMedID- 20490716 The coexistence of type 2 diabetes with breast cancer may result in poorer cancer-related survival due to a number of mediating factors including an alteration of tumor tissue hormonal sensitivity.
PubMedID- 24564865 For example, thioethershave therapeutic potential for treatment of hiv,1 breast cancer,2 inflammatorydiseases,3,4 diabetes,5 andalzheimer’s disease.6 despite theirabundance, until recently few general methods were available for theirsynthesis under mild conditions that would tolerate sensitive heterocycles.in this manuscript, we report synthesis of diaryl sulfides by in situformation of highly reactive sulfenyl chlorides and subsequent trappingwith arylzinc reagents.
PubMedID- 25877238 Objective: to explore the expression of hypoxia-inducible factor 1 alpha (hif-1alpha) in tissue of breast cancer complicated with diabetes and examine the correlation with vascular endothelial growth factor (vegf) and microvascular density (mvd).
PubMedID- 24834121 In a second study, dr fontanella and colleagues investigated the incidence of type 2 diabetes in patients with early breast cancer at the time of diagnosis, as well as its effect on the outcome after neoadjuvant chemotherapy.
PubMedID- 26171112 Epidemiological findings indicate a close relationship between diabetes and many types of cancer (including breast cancer risk), which regards not only the dysmetabolic condition, but also its underlying risk factors and therapeutic interventions.
PubMedID- 24869799 Higher body mass index (bmi) and diabetes are associated with worse breast cancer prognosis.
PubMedID- 23238788 Methods: we used population-based data from ontario, canada to compare the incidence of diabetes among women with breast cancer, aged 55 years or older, from 1996 to 2008, with that of age-matched women without breast cancer.
PubMedID- 25971328 diabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproduction.
PubMedID- 26446233 Results: a total of 11 studies consisting of 5,464 breast cancer patients with diabetes were included, comprising 2,760 patients who had received metformin and 2,704 patients who had not.
PubMedID- 21614572 Conclusions/interpretation: the risk of breast cancer in women with type 2 diabetes is not increased during the first 5 years of insulin glargine use.
PubMedID- 24096546 The subjects included 680 breast cancer patients with diabetes and 5,105 breast cancer patients without diabetes.
PubMedID- 24937172 Background and aims: although underlying mechanisms have been described to account for the association between prediabetes and diabetes with breast cancer, reported results have been inconsistent.
PubMedID- 25261292 Thus, the continuum of care for breast cancer patients with diabetes should include careful attention to cvd risk factors and other non-cancer conditions.
PubMedID- 24587242 Moreover, it has been reported that there are difference between the breast cancer patients with diabetes and their nondiabetic counterparts in the regimen choice and effects of breast cancer treatment [1], [2], [4].
PubMedID- 25854171 The objective of this study was to investigate the clinical pathological characteristics of breast cancer (bc) patients with secondary diabetes after systemic therapy without preexisting diabetes.
PubMedID- 24899083 We examined whether receipt of guideline-concordant breast cancer treatment varied with diabetes severity.
PubMedID- 20625814 Relationship between diabetes and risk of second primary contralateral breast cancer.
PubMedID- 21357383 No association of risk variants for diabetes and obesity with breast cancer: the multiethnic cohort and page studies.
PubMedID- 24026538 Conclusion: when taking competing mortality into account, rfp was better in elderly breast cancer patients with diabetes compared with patients without diabetes.
PubMedID- 26148588 Aim: we tend to explore the expression characteristics of proteins in igf/ir axis in breast cancer with type 2 diabetes mellitus (t2dm).
PubMedID- 26472977 We searched the pubmed and embase databases (from inception to february 10, 2015) for randomized and observational studies that discussed the association between metformin and breast cancer in patients with diabetes mellitus, by using the following search terms: "metformin" and "breast cancer."

Page: 1 2